Mo. Code Regs. Ann. tit. 20, § 2220-2.195
Prospective Drug Utilization Review
Effective Feb 28, 2021sections 338.100 and 338.280, RSMo 2016, and sections 338.035 and 338.140, RSMo Supp. 2020.* Original rule filed Sept. 1, 2020, effective Feb. 28, 2021. *Original authority: 338.035, RSMo 1990, amended 1993, 1995, 2007, 2020; 338.100, RSMo 1939, amended 1971, 1990, 1997, 1999, 2010, 2016; 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019; and 338.280, RSMo 1951, amended 1971, 1981State Board of Pharmacy
PURPOSE: This rule establishes requirements for prospective drug utilization review prior to dispensing a prescription or medication order.
(1) Prospective Drug Review.
- (A) Prior to dispensing or otherwise approving medication for patient use, pharmacists shall use their professional judgment to review available patient records to assess therapeutic appropriateness.
- (B) The pharmacist shall take appropriate steps within their professional judgment to address or resolve identified therapeutic appropriateness issues. Prospective drug review may only be performed by a pharmacist or an intern pharmacist working under the supervision of a Missouri licensed pharmacist.
AUTHORITY: sections 338.100 and 338.280, RSMo 2016, and sections 338.035 and 338.140, RSMo Supp. 2020.* Original rule filed Sept. 1, 2020, effective Feb. 28, 2021. *Original authority: 338.035, RSMo 1990, amended 1993, 1995, 2007, 2020; 338.100, RSMo 1939, amended 1971, 1990, 1997, 1999, 2010, 2016; 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019; and 338.280, RSMo 1951, amended 1971, 1981.